These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33269267)

  • 1. Successful treatment of a high-risk nonseminomatous germ cell tumor using etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine: A case report.
    Yun J; Lee SW; Lim SH; Kim SH; Kim CK; Park SK
    World J Clin Cases; 2020 Nov; 8(21):5334-5340. PubMed ID: 33269267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
    Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
    Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    Mao Y; Wan X; Lv W; Xie X
    Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia.
    Turan T; Karacay O; Tulunay G; Boran N; Koc S; Bozok S; Kose MF
    Int J Gynecol Cancer; 2006; 16(3):1432-8. PubMed ID: 16803542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
    Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
    Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: a preliminary report.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Fujisawa M
    Int J Urol; 2010 Oct; 17(10):881-5. PubMed ID: 20731738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
    Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
    Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 12. Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.
    Hiramatsu Y; Masuyama H; Ishida M; Murakami K; Sakurai M
    Acta Med Okayama; 2005 Oct; 59(5):235-8. PubMed ID: 16286962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
    Sato S; Yamamoto E; Niimi K; Ino K; Nishino K; Suzuki S; Kotani T; Kajiyama H; Kikkawa F
    Int J Clin Oncol; 2020 Jan; 25(1):203-209. PubMed ID: 31520175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
    Bilgin T; Ozan H; Ozuysal S; Ozkan L
    Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 18. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.